by Bill Malloy | May 23, 2022 | Health, Medication, Pharmaceuticals
In November 2021, a cancer treatment agent called Cytalux was approved by the US Food and Drug Administration (FDA). Between 22,000 and 24,000 women are diagnosed with ovarian cancer each year in the United States. Oncologists are hopeful that this new treatment can...
by Bill Malloy | May 16, 2022 | Health, Medication, Scientists
Colorectal cancer is one of the most common forms of cancer and, as the second-leading cause of cancer deaths, it is also one of the most serious. For years, cancer researchers have been searching for ways to prevent and treat colorectal cancer more...
by Bill Malloy | Jul 15, 2021 | Health, Medication, Pharmaceuticals, Scientists, Technology
The COVID-19 pandemic sparked the rapid development of new vaccine technologies in a matter of months. For the first time in history, vaccines using synthetic messenger RNA (mRNA) technology were created. However, administrating the vaccine has proven more difficult...
by Bill Malloy | Jul 8, 2021 | Health, Medication, Technology
Healthcare startups are introducing new ideas that could redefine the field in the United States and around the world. One company making headlines recently is Texas Medical Technology, whose subsidiary, iNitrile, has developed a system to dispense personal protective...
by Bill Malloy | Apr 28, 2021 | Data, Health, Medication, Pharmaceuticals, Scientists, Technology
One of the technologies that has received a lot of attention in digital health in the past few years is the smart pill. These pills are small electronic devices that are shaped like a pharmaceutical capsule so that they can be easily swallowed. The pills safely travel...
by Bill Malloy | Mar 24, 2021 | Health, Medication, Scientists, Technology
In 2020, the Nobel Prize in Chemistry went to microbiologist Dr. Emmanuelle Charpentier and biochemist Jennifer Doudna for the development of technology known as clustered regularly interspaced short palindromic repeats (CRISPR). The technology has often been referred...
